SD HEALTHCARERecent and archived news stories on: Biotechnology, Doctors, Drugs, Health Insurance, HMO's/PPO's, Hospitals, Medical Devices, Nursing...
Starting Oct. 1, San Diego-area employers with 25 or more workers may schedule a visit from a U.S. HealthWorks clinician who can provide on-site flu vaccinations and educational information.
Local trade group California Life Sciences Association is expanding its footprint to Los Angeles, with a new L.A. office and partnerships with LA BioMed and Lab Launch.
Franz Och, a former Google executive recruited in 2014 by J. Craig Venter’s Human Longevity, has left the firm for an opportunity with Illumina-backed Grail.
San Diego life science upstart Fortis Therapeutics Inc. has closed an $18 million Series A round led by local venture capital firm Avalon Ventures.
Fate Therapeutics Inc.'s lead investigative product, ProTmune, has been granted Orphan Drug Designation by the U.S. Food and Drug Administration.
La Jolla-based National University announced it is collaborating with a pair of telehealth companies, including a locally based wireless device developer, to connect patients in Los Angeles County with nurse practitioners working remotely.
San Diego’s Imprimis Pharmaceuticals, a maker of compounded drugs, is reducing its expenses in hopes of reaching near-term profitability, the company announced Monday.
Scripps Health unveiled a $33 million, 33,000-square-foot emergency and trauma center set to open Sept. 26 on the first floor of the Prebys Cardiovascular Institute on the campus of Scripps Memorial Hospital La Jolla.
Pharmaceutical giant Allergan Plc has acquired Akarna Therapeutics Inc. for $50 million.
San Diego biopharma Apricus Biosciences Inc. is expected to raise $4.6 million in a direct offering of its common stock to institutional investors, the company said Sept. 23.
Mast Terminates Clinical Development of Sickle Cell Drug Following Poor Results; Co.'s Stock Plunges
The stock of local biotech Mast Therapeutics Inc. has plummeted nearly 80 percent following news of lousy clinical trial results.
L.A. County-based Xencor Inc. is expanding its operations into San Diego, the company announced Thursday.
Local drugmaker Cidara Therapeutics Inc. has identified a new research target that could potentially treat bacterial infections that have formed resistance to multiple drugs on the market, the company said Wednesday.
A subsidiary of San Diego’s staffing giant AMN Healthcare Services is making a private offering of $300 million in senior notes, according to an AMN news release.